A year ago, almost no one wore masks or stayed 6 feet apart from others. Some of these behaviors have become social norms at light speed—something those of us who have made social and behavior change communication our life’s work rarely see. Getting a vaccine needs to…

Neglected tropical diseases—a group of parasitic, bacterial, and viral infections affecting more than 1.7 billion people globally—have held back human progress for millennia, disabling, debilitating, and causing early death if left untreated. Yet NTDs struggle to attract…

A year after the first COVID-19 case was reported in Wuhan, China, few countries have fully contained the disease. Those that have share few, if any, political similarities.

One Friday last month, I posted a map on Twitter. It drew immediate global attention, was seen by 8 million people, and has provoked strong responses and anger—and hopefully some soul-searching among those in governments and pharmaceutical companies.

In a world of gloomy global health news, progress against the leading cause of contagious and irreversible blindness—trachoma—is heartening. The WHO has reported a remarkable 91% reduction in people at risk of contracting the neglected tropical disease since 2002.

With the built-in injustices of the US health care system on full display as COVID-19 ravages communities, imagine that Switzerland, France, and Spain—which all fare better in health system efficiency—band together to redesign US health care.

“Our house is still on fire… and we should act as though we love our children above all else.” Perched on a stool to reach the microphone, an unwavering Greta Thunberg challenged the global elite with those words at the World Economic Forum in Davos early this year, just…

Much of the current COVID-19 discussion across the US focuses on choreographing a transition from what has been called the “hammer” of lockdowns to the “dance” of a carefully staged easing of certain restrictions.   

Full-scale efforts are underway to develop a vaccine free us from COVID-19’s deadly grip. But even if they succeed (and that’s no guarantee), the question regrettably must be asked: Will people take it?